The ibuprofen API market share is forecast to reach USD 31.68 million, after growing at a CAGR of 2.53% during 2023-2027. The increasing geriatric population is analyzed to boost the ibuprofen API market growth. Moreover, the paradigm shift in API manufacturing is the major trend enhancing the overall market demand for (keyword) during the forecast period.
Get a snapshot of the ibuprofen API market analysis: Unlock the Sample Report The report includes historic market data from 2017 to 2021. In 2017, the market was valued at USD 219.50 million.
Browse Technavio's 151-page report and in-depth TOC on "Ibuprofen API Market by end-user (pharmaceutical companies and contract manufacturing organizations), product (prescription and over-the-counter), and geography (Asia, North America, Europe, and Rest of World (ROW)."
View detailed Table of Contents Here: https://www.technavio.com/report/ibuprofen-api-market-analysis
End-user:
Pharmaceutical companies: The market share growth by the pharmaceutical companies segment will be significant during the forecast period. Ibuprofen API is also used in the treatment of various conditions, such as rheumatoid arthritis and osteoarthritis.
Contract manufacturing organizations
Geography:
Asia: Asia is estimated to contribute 42% to the growth of the global market during the forecast period. The growth of the ibuprofen active pharmaceutical ingredient (API) market is attributed to factors such as the growing prevalence of migraine, chronic disorders, and other disorders.
North America
Europe
Rest of World (ROW)
Product :
Prescription
Over-the-counter
The ibuprofen API market size will witness a YOY Growth Rate of 1.76% in 2023.
The stringent regulations on ibuprofen API will be a major challenge for the ibuprofen API market during the forecast period.
Major key ibuprofen API market players include: Arch Pharmalabs Ltd., Athos Chemicals Pvt. Ltd., Azelis SA, BASF SE, Chemino Pharma Ltd., Dr Reddys Laboratories Ltd., Granules India Ltd., HELM AG, IOL Chemicals and Pharmaceuticals Ltd., Mallinckrodt Plc, Octavius Pharma Pvt Ltd., Piramal Enterprises Ltd., Rochem International Inc., SI Group Inc., Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd., Solara Active Pharma Sciences Ltd., Strides Pharma Science Ltd., Teva Pharmaceutical Industries Ltd., Titan Lab Pvt Ltd., and Otto Brandes GmbH
The report illustrates the lifecycle of the market, focusing on the adoption rates of the major regions such as the Asia, North America, Europe, and Rest of World (ROW).
Download the PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth.
Precise market size estimation during the forecast period 2023-2027.
CAGR of the ibuprofen API market forecast during 2023-2027.
Market-level data on units, average selling prices, and values of the ibuprofen API market share.
Prediction of the upcoming trends, drivers, and factors that challenge the growth of the ibuprofen API market.
ibuprofen API industry growth across Asia, North America, Europe, and Rest of World (ROW).
